Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1994 | 06-1994 | 03-1994 | 12-1993 | 09-1993 | |
| Sales | 1,507,300 | 1,678,500 | 1,309,100 | 1,800,800 | 1,530,600 |
| Cost of Goods | 451,400 | 385,800 | 382,100 | 575,500 | 467,400 |
| Gross Profit | 1,055,900 | 961,000 | 927,000 | 1,225,300 | 1,063,200 |
| Operating Expenses | 580,300 | 533,600 | 457,400 | 778,600 | 650,500 |
| Operating Income | 476,000 | 759,900 | 469,700 | 447,200 | 413,100 |
| Interest Expense | 15,300 | 18,700 | 16,700 | 0 | 0 |
| Other Income | -33,900 | -280,700 | -20,200 | -1,184,600 | 4,500 |
| Pre-tax Income | 426,800 | 460,500 | 432,800 | -737,400 | 417,600 |
| Income Tax | 131,200 | 141,300 | 132,100 | -213,800 | 123,200 |
| Net Income Continuous | 295,600 | 346,600 | 300,700 | -523,600 | 294,400 |
| Net Income Discontinuous | 23,100 | 0 | 30,000 | 0 | 0 |
| Net Income | $318,700 | $346,600 | $330,700 | $-523,600 | $294,400 |
| EPS Basic Total Ops | 0.28 | 0.30 | 0.29 | -0.44 | 0.25 |
| EPS Basic Continuous Ops | 0.26 | 0.30 | 0.26 | -0.44 | 0.25 |
| EPS Basic Discontinuous Ops | 0.02 | N/A | 0.03 | N/A | N/A |
| EPS Diluted Total Ops | 0.28 | 0.30 | 0.29 | -0.44 | 0.25 |
| EPS Diluted Continuous Ops | 0.26 | 0.30 | 0.26 | -0.45 | 0.25 |
| EPS Diluted Discontinuous Ops | 0.02 | N/A | 0.03 | N/A | N/A |
| EBITDA(a) | $476,000 | $759,900 | $469,700 | $447,200 | $413,100 |